Several epidemiological studies have shown that the plasma level and activity of lp-PLA2 increase during the development of atherosclerosis, supporting its utility as a marker for cardiovascular risk [14], [15], [16], [17], [18]. The gene discussed is PLA2G7; the disease is atherosclerosis.